NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-MH-19-043 from the NIH Guide for Grants and Contracts
Notice NOT-NR-19-010 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-OD-19-028 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.
Notice NOT-AG-19-046 from the NIH Guide for Grants and Contracts
Notice NOT-HS-19-021 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-149 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-150 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-MD-20-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from eligible institutions of higher education for specialized center grants to support multidisciplinary research, research capacity building, and community-engaged research activities focused on understanding and reducing or eliminating environmental health disparities, defined as inequities in population health mediated by disproportionate adverse exposures associated with the physical, chemical, social and built environments.
Funding Opportunity RFA-CA-19-059 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to continue support for the Pediatric Brain Tumor Consortium (PBTC). This Limited-Competition FOA solicits a single application from the current PBTC awardee. The PBTC was conceived as a dedicated clinical trials organization able to translate innovative therapies from the laboratory to early phase clinical testing so that treatment for primary brain tumors in children can be improved. The importance of the PBTC is highlighted by the continuing high mortality rate among some common brain tumors occurring in children [e.g., diffuse intrinsic pontine gliomas (DIPG), malignant supratentorial gliomas, and biologically high-risk medulloblastomas and ependymomas] and the functional impediments apparent in a large proportion of children surviving current therapies. The PBTC is designed to fill a unique niche in the NIH pediatric brain tumor research portfolio through its ability to translate multiple innovative therapies from the laboratory to early phase clinical testing.
Notice NOT-NR-19-011 from the NIH Guide for Grants and Contracts
Notice NOT-HD-19-032 from the NIH Guide for Grants and Contracts
Notice NOT-HD-19-031 from the NIH Guide for Grants and Contracts
Notice NOT-GM-19-060 from the NIH Guide for Grants and Contracts
Notice NOT-CA-19-071 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AA-20-003 from the NIH Guide for Grants and Contracts. The objective of the NADIA consortium is to investigate persistent changes in complex brain function-behavior relationships following adolescent alcohol exposure. The Consortium model provides a mechanism for fostering interdisciplinary cooperation with a group of established investigators conducting exceptional alcohol research at different institutions. The purpose of this initiative is to continue support for collaborative research projects focusing on research efforts across different research institutions investigating the consequences of repeated adolescent alcohol exposure on brain maturation and adult abilities. Because NIAAA is interested in supporting experimental studies on the effects of controlled alcohol doses and exposure periods, this initiative is limited to animal studies only. T
Funding Opportunity RFA-AA-20-004 from the NIH Guide for Grants and Contracts. The objective of the NADIA consortium is to investigate persistent changes in complex brain function-behavior relationships following adolescent alcohol exposure. The Consortium model provides a mechanism for fostering interdisciplinary cooperation with a group of established investigators conducting exceptional alcohol research at different institutions. The purpose of this initiative is to continue support for collaborative research projects focusing on research efforts across different research institutions investigating the consequences of repeated adolescent alcohol exposure on brain maturation and adult abilities. Because NIAAA is interested in supporting experimental studies on the effects of controlled alcohol doses and exposure periods, this initiative is limited to animal studies only.
Funding Opportunity RFA-AA-20-005 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism intends to renew an initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for Research Resources -Cooperative Agreements (U24) to provide technical and scientific support to the research projects (U01) as part of the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA). The objective of the NADIA consortium is to investigate persistent changes in complex brain function-behavior relationships following adolescent alcohol exposure.
Notice NOT-GM-19-059 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-20-003 from the NIH Guide for Grants and Contracts. This FOA solicits Research Education Grant (R25) applications to develop and implement a short course focused on (1) steps required for successful medical device development and translation, (2) common technical and strategic challenges, and (3) best-practices and resources for each stage in the process. Applicants may choose to include an extended mentorship plan if they see fit. The short course should address a broad audience, including senior post-doctoral fellows, independent academic researchers, clinician scientists, and small business entrepreneurs interested in developing and translating medical devices to diagnose or treat a nervous system disorder.
Notice NOT-HD-19-023 from the NIH Guide for Grants and Contracts